BIT
ALXA

BlackRock Institutional Trust’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

BlackRock Institutional Trust’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-47,674
Closed -$111K – 3950
2014
Q3 		$111K Sell
47,674
-91,432
-66% -$349K ﹤0.01% 3668
2014
Q2 		$636K Sell
139,106
-9,107
-6% -$39.3K ﹤0.01% 3522
2014
Q1 		$657K Sell
148,213
-1,688
-1% -$8.66K ﹤0.01% 3524
2013
Q4 		$709K Buy
149,901
+10,412
+7% +$51.1K ﹤0.01% 3495
2013
Q3 		$714K Buy
+139,489
New +$656K ﹤0.01% 3443

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
HHMI
Howard Hughes Medical Institute Chevy Chase, Maryland $416M AUM 13.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock Institutional Trust's ALXA Position: Q4 2014 in Review

BlackRock Institutional Trust sold out of Alexza Pharmaceuticals Inc (ALXA) in Q4 2014, closing a stake of 47,674 shares — an estimated $111K sold.

BlackRock Institutional Trust first reported a position in ALXA in Q3 2013 and held it in 5 quarters. The position peaked at $714K in Q3 2013. 31 funds tracked by Wall St. Rank hold ALXA as of Q4 2014.

  • BlackRock Institutional Trust reported no remaining Alexza Pharmaceuticals Inc position as of Q4 2014 after selling out during the quarter.
  • BlackRock Institutional Trust sold 47,674 Alexza Pharmaceuticals Inc shares in Q4 2014, an estimated $111K.
  • BlackRock Institutional Trust first reported a position in Alexza Pharmaceuticals Inc in Q3 2013 and held it in 5 quarters.
  • BlackRock Institutional Trust's Alexza Pharmaceuticals Inc position peaked at $714K in Q3 2013.
  • 31 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q4 2014.

Based on BlackRock Institutional Trust's 13F filing for Q4 2014, filed 9 Feb 2015.